Pharmaceutical firms wary of drug-related pricing polices

Published: 2003-01-20 07:00:00

Updated: 2003-01-20 07:00:00

With the next government's inception one month away, domestic pharmaceutical industry remains cautious of President-elect Roh Moo-hyun's pledges during election - drug price contract system and gross budge system, along with the implementation of reference price system which has been withheld so ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK